Cargando…
Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898039/ https://www.ncbi.nlm.nih.gov/pubmed/29649990 http://dx.doi.org/10.1186/s12885-018-4200-5 |
_version_ | 1783314059046682624 |
---|---|
author | Brogden, Kim A. Parashar, Deepak Hallier, Andrea R. Braun, Terry Qian, Fang Rizvi, Naiyer A. Bossler, Aaron D. Milhem, Mohammed M. Chan, Timothy A. Abbasi, Taher Vali, Shireen |
author_facet | Brogden, Kim A. Parashar, Deepak Hallier, Andrea R. Braun, Terry Qian, Fang Rizvi, Naiyer A. Bossler, Aaron D. Milhem, Mohammed M. Chan, Timothy A. Abbasi, Taher Vali, Shireen |
author_sort | Brogden, Kim A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5898039 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58980392018-04-20 Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy Brogden, Kim A. Parashar, Deepak Hallier, Andrea R. Braun, Terry Qian, Fang Rizvi, Naiyer A. Bossler, Aaron D. Milhem, Mohammed M. Chan, Timothy A. Abbasi, Taher Vali, Shireen BMC Cancer Correction BioMed Central 2018-04-12 /pmc/articles/PMC5898039/ /pubmed/29649990 http://dx.doi.org/10.1186/s12885-018-4200-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Correction Brogden, Kim A. Parashar, Deepak Hallier, Andrea R. Braun, Terry Qian, Fang Rizvi, Naiyer A. Bossler, Aaron D. Milhem, Mohammed M. Chan, Timothy A. Abbasi, Taher Vali, Shireen Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy |
title | Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy |
title_full | Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy |
title_fullStr | Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy |
title_full_unstemmed | Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy |
title_short | Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy |
title_sort | correction to: genomics of nsclc patients both affirm pd-l1 expression and predict their clinical responses to anti-pd-1 immunotherapy |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898039/ https://www.ncbi.nlm.nih.gov/pubmed/29649990 http://dx.doi.org/10.1186/s12885-018-4200-5 |
work_keys_str_mv | AT brogdenkima correctiontogenomicsofnsclcpatientsbothaffirmpdl1expressionandpredicttheirclinicalresponsestoantipd1immunotherapy AT parashardeepak correctiontogenomicsofnsclcpatientsbothaffirmpdl1expressionandpredicttheirclinicalresponsestoantipd1immunotherapy AT hallierandrear correctiontogenomicsofnsclcpatientsbothaffirmpdl1expressionandpredicttheirclinicalresponsestoantipd1immunotherapy AT braunterry correctiontogenomicsofnsclcpatientsbothaffirmpdl1expressionandpredicttheirclinicalresponsestoantipd1immunotherapy AT qianfang correctiontogenomicsofnsclcpatientsbothaffirmpdl1expressionandpredicttheirclinicalresponsestoantipd1immunotherapy AT rizvinaiyera correctiontogenomicsofnsclcpatientsbothaffirmpdl1expressionandpredicttheirclinicalresponsestoantipd1immunotherapy AT bossleraarond correctiontogenomicsofnsclcpatientsbothaffirmpdl1expressionandpredicttheirclinicalresponsestoantipd1immunotherapy AT milhemmohammedm correctiontogenomicsofnsclcpatientsbothaffirmpdl1expressionandpredicttheirclinicalresponsestoantipd1immunotherapy AT chantimothya correctiontogenomicsofnsclcpatientsbothaffirmpdl1expressionandpredicttheirclinicalresponsestoantipd1immunotherapy AT abbasitaher correctiontogenomicsofnsclcpatientsbothaffirmpdl1expressionandpredicttheirclinicalresponsestoantipd1immunotherapy AT valishireen correctiontogenomicsofnsclcpatientsbothaffirmpdl1expressionandpredicttheirclinicalresponsestoantipd1immunotherapy |